Adlai Nortye Ltd. American Depositary Shares Earnings

The next earnings date for Adlai Nortye Ltd. American Depositary Shares has not yet been scheduled.

Analyst Estimates of Adlai Nortye Ltd. American Depositary Shares Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Adlai Nortye Ltd. American Depositary Shares Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
02/25/2026---$0---
12/03/2025---$0---
08/22/2025---$0---
08/15/2025---$0---
08/07/2025---$0---
02/28/2024---$0100.00%
11/29/2023---$-0.240.00%
08/30/2023---$-1.94---

More About Adlai Nortye Ltd. American Depositary Shares

Country
USA
Full Time Employees
123

Adlai Nortye Ltd., a clinical-stage biotechnology company, engages in the research and develops pharmaceutical products in the United States and internationally. Its lead product is AN8025, a tri-functional fusion protein of aPD-L1 x CD86 variant x LAG3 variant, a T-cell and antigen-presenting cell modulator, which is in phase 1a clinical trials for the treatment of tumor. The company also developing AN9025, an oral small molecule pan-RAS(ON) inhibitor, which is in phase 1a clinical trials for the treatment of RAS-mutant cancers include pancreatic, lung, and colorectal adenocarcinomas; and AN4005, a first-in-class oral small-molecule PD-L1 inhibitor, which is in phase 1b treatment for tumor to activate cancer immunity. It is also developing AN0025, a small molecule EP4 antagonist, which is in phase 1b clinical trials for the treatment of locally advanced esophageal cancer (+chemoradiation therapy), and radiotherapy which is in phase 2 clinical trials for the treatment of rectal cancer (+chemoradiation therapy). Adlai Nortye Ltd. was founded in 2004 and is based in Grand Cayman, the Cayman Islands.

Adlai Nortye Ltd. American Depositary Shares Earnings” Can Refer to the Adlai Nortye Ltd. American Depositary Shares Earnings Date

Some people say “Adlai Nortye Ltd. American Depositary Shares earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Adlai Nortye Ltd. American Depositary Shares position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Adlai Nortye Ltd. American Depositary Shares Stock on the Earnings Date

If you own Adlai Nortye Ltd. American Depositary Shares stock (ANL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Adlai Nortye Ltd. American Depositary Shares might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Adlai Nortye Ltd. American Depositary Shares shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Adlai Nortye Ltd. American Depositary Shares Earnings

You can contact us any time if you would like to ask questions about Adlai Nortye Ltd. American Depositary Shares earnings or anything else related to the stock market.